Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial

Ehrenreich, Hannelore; Hasselblatt, Martin; Dembowski, Christoph; Cepek, Lukas; Lewczuk, Piotr; Stiefel, Michael; Rustenbeck, Hans-Heino; Breiter, N; Jacob, Sonja; Knerlich‐Lukoschus, Friederike; Bohn, Matthias; Poser, W.; Rüther, Eckart; M. Kochen, Michael; Gefeller, Olaf; H. Gleiter, Christoph; Wessel, Thomas; De Ryck, Marc; M. Itri, Loretta; Prange, Hilmar; Cerami, Anthony; Brines, Michael; Sirén, Anna‐Leena

doi:10.1007/bf03402029

Public

Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial

Shared by NobleBlocks on Aug 1, 2002 • 12:00 AM UTC

Authors:

Hannelore Ehrenreich

Martin Hasselblatt

Christoph Dembowski

Abstract

Intravenous high-dose rhEPO is well tolerated in acute ischemic stroke and associated with an improvement in clinical outcome at 1 month. A larger scale clinical trial is warranted.

Subject

Medicine

Erythropoietin

Fluid-attenuated inversion recovery

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!